Cai, H.; Agersnap, S.N.; Sjøgren, A.; Simonsen, M.K.; Blaavand, M.S.; Jensen, U.V.; Thomsen, M.K.
In Vivo Application of CRISPR/Cas9 Revealed Implication of Foxa1 and Foxp1 in Prostate Cancer Proliferation and Epithelial Plasticity. Cancers 2022, 14, 4381.
https://doi.org/10.3390/cancers14184381
AMA Style
Cai H, Agersnap SN, Sjøgren A, Simonsen MK, Blaavand MS, Jensen UV, Thomsen MK.
In Vivo Application of CRISPR/Cas9 Revealed Implication of Foxa1 and Foxp1 in Prostate Cancer Proliferation and Epithelial Plasticity. Cancers. 2022; 14(18):4381.
https://doi.org/10.3390/cancers14184381
Chicago/Turabian Style
Cai, Huiqiang, Simon N. Agersnap, Amalie Sjøgren, Mikkel K. Simonsen, Mathilde S. Blaavand, Ulrikke V. Jensen, and Martin K. Thomsen.
2022. "In Vivo Application of CRISPR/Cas9 Revealed Implication of Foxa1 and Foxp1 in Prostate Cancer Proliferation and Epithelial Plasticity" Cancers 14, no. 18: 4381.
https://doi.org/10.3390/cancers14184381
APA Style
Cai, H., Agersnap, S. N., Sjøgren, A., Simonsen, M. K., Blaavand, M. S., Jensen, U. V., & Thomsen, M. K.
(2022). In Vivo Application of CRISPR/Cas9 Revealed Implication of Foxa1 and Foxp1 in Prostate Cancer Proliferation and Epithelial Plasticity. Cancers, 14(18), 4381.
https://doi.org/10.3390/cancers14184381